Thailand is strengthening its defenses against COVID-19 for about 500,000 immunocompromised people who – vaccinated or otherwise – remain vulnerable. This extra protection comes in the form of AstraZeneca’s long-acting antibody (LAAB) combination. The antibody combination is produced by AstraZeneca under the name Evusheld. It comprises tixagevimab and cilgavimab – a combination that helps protect … Continue reading COVID still a killer for 500,000 vulnerable people – but Thailand has new defense